These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

57 related items for PubMed ID: 3872870

  • 1. Dominant and recessive mitogen-nonproliferative variants of 3T3 cells.
    Terwilliger E, Herschman HR.
    J Cell Physiol; 1985 Jun; 123(3):321-5. PubMed ID: 3872870
    [Abstract] [Full Text] [Related]

  • 2. Variants of 3T3 cells lacking mitogenic response to the tumor promoter tetradecanoyl-phorbol-acetate.
    Butler-Gralla E, Herschman HR.
    J Cell Physiol; 1981 Apr; 107(1):59-67. PubMed ID: 6971296
    [Abstract] [Full Text] [Related]

  • 3. Phorbol diester and epidermal growth factor receptors in 12-O-tetradecanoylphorbol-13-acetate-resistant and -sensitive mouse epidermal cells.
    Colburn NH, Gindhart TD, Hegamyer GA, Blumberg PM, Delclos KB, Magun BE, Lockyer J.
    Cancer Res; 1982 Aug; 42(8):3093-7. PubMed ID: 6284358
    [Abstract] [Full Text] [Related]

  • 4. Mitogenic effects of murine serum and fibroblast growth factor on EGF nonproliferative variants of 3T3.
    Pruss RM, Herschman HR.
    J Supramol Struct; 1979 Aug; 12(4):467-70. PubMed ID: 317717
    [Abstract] [Full Text] [Related]

  • 5. Responses of preneoplastic epidermal cells to tumor promoters and growth factors: use of promoter-resistant variants for mechanism studies.
    Colburn NH, Wendel E, Srinivas L.
    J Cell Biochem; 1982 Aug; 18(3):261-70. PubMed ID: 7068782
    [Abstract] [Full Text] [Related]

  • 6. Effects of retinoic acid on the binding and mitogenic activity of epidermal growth factor.
    Jetten AM.
    J Cell Physiol; 1982 Mar; 110(3):235-40. PubMed ID: 6282898
    [Abstract] [Full Text] [Related]

  • 7. Variants of 3T3 cells lacking mitogenic response to epidermal growth factor.
    Pruss RM, Herschman HR.
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):3918-21. PubMed ID: 302945
    [Abstract] [Full Text] [Related]

  • 8. Glucose uptake and ornithine decarboxylase activity in tetradecanoyl phorbol acetate non-proliferative variants.
    Butler-Gralla E, Herschman HR.
    J Cell Physiol; 1983 Mar; 114(3):317-20. PubMed ID: 6833404
    [Abstract] [Full Text] [Related]

  • 9. Induction of tumor promotor-inducible genes in murine 3T3 cell lines and tetradecanoyl phorbol acetate-nonproliferative 3T3 variants can occur through protein kinase C-dependent and -independent pathways.
    Lim RW, Varnum BC, O'Brien TG, Herschman HR.
    Mol Cell Biol; 1989 Apr; 9(4):1790-3. PubMed ID: 2471069
    [Abstract] [Full Text] [Related]

  • 10. Hexose uptake as an indicator of JB6 mouse epidermal cell resistance to the mitogenic activity of TPA.
    Copley M, Gindhart T, Colburn N.
    J Cell Physiol; 1983 Feb; 114(2):173-8. PubMed ID: 6822609
    [Abstract] [Full Text] [Related]

  • 11. Intercellular heterogeneity of early mitogenic events: cAMP generalizes the EGF effect on c-Fos protein appearance but not on MAP kinase phosphorylation and nuclear translocation in dog thyroid epithelial cells.
    Baptist M, Dumont JE, Roger PP.
    Exp Cell Res; 1995 Nov; 221(1):160-71. PubMed ID: 7589241
    [Abstract] [Full Text] [Related]

  • 12. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.
    Li J, Ma C, Huang Y, Luo J, Huang C.
    Oncogene; 2003 Jan 16; 22(2):211-9. PubMed ID: 12527890
    [Abstract] [Full Text] [Related]

  • 13. Role of epidermal growth factor-stimulated protein kinase in control of proliferation of A431 cells.
    Gill GN, Buss JE, Lazar CS, Lifshitz A, Cooper JA.
    J Cell Biochem; 1982 Jan 16; 19(3):249-57. PubMed ID: 6296169
    [Abstract] [Full Text] [Related]

  • 14. Effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) on the growth inhibitory and increased phosphatidylinositol (PI) responses induced by epidermal growth factor (EGF) in A431 cells.
    Smith KB, Losonczy I, Sahai A, Pannerselvam M, Fehnel P, Salomon DS.
    J Cell Physiol; 1983 Oct 16; 117(1):91-100. PubMed ID: 6311852
    [Abstract] [Full Text] [Related]

  • 15. Regulation by ceramide of epidermal growth factor signal transduction and mitogenesis in cell lines overexpressing the growth factor receptor.
    Gallardo G, Tabraue C, Quintana J, López-Blanco F, Cabrera J, Díaz R, Estévez F, Ruiz de Galarreta CM, Fanjul LF, Santana P.
    Cell Mol Biol (Noisy-le-grand); 2000 Nov 16; 46(7):1305-12. PubMed ID: 11075960
    [Abstract] [Full Text] [Related]

  • 16. 3T3 variants unable to bind epidermal growth factor cannot complement in co-culture.
    Terwilliger E, Herschman HR.
    Biochem Biophys Res Commun; 1984 Jan 13; 118(1):60-4. PubMed ID: 6320832
    [Abstract] [Full Text] [Related]

  • 17. Sarcoma growth factor (SGF): specific binding to epidermal growth factor (EGF) membrane receptors.
    De Larco JE, Todaro GJ.
    J Cell Physiol; 1980 Feb 13; 102(2):267-77. PubMed ID: 6246130
    [Abstract] [Full Text] [Related]

  • 18. A 12-O-tetradecanoylphorbol-13-acetate (TPA)-nonproliferative variant of 3T3 cells is resistant to TPA-enhanced gene amplification.
    Herschman HR.
    Mol Cell Biol; 1985 May 13; 5(5):1130-5. PubMed ID: 4000120
    [Abstract] [Full Text] [Related]

  • 19. Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha.
    Reddy CC, Wells A, Lauffenburger DA.
    J Cell Physiol; 1996 Mar 13; 166(3):512-22. PubMed ID: 8600155
    [Abstract] [Full Text] [Related]

  • 20. Engineering epidermal growth factor for enhanced mitogenic potency.
    Reddy CC, Niyogi SK, Wells A, Wiley HS, Lauffenburger DA.
    Nat Biotechnol; 1996 Dec 13; 14(13):1696-9. PubMed ID: 9634854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.